AVASARALA, J. DRESS Syndrome and Daclizumab Failure-Were Potentially Dangerous Signs Missed in Clinical Trials. Drug Target Insights, [S. l.], v. 12, n. 1, 2018. DOI: 10.33393/dti.2018.1401. Disponível em: https://journals.aboutscience.eu/index.php/dti/article/view/1401. Acesso em: 21 nov. 2024.